Sonnet BioTherapeutics Inc (SONN): Apparently not

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Sonnet BioTherapeutics Inc (SONN)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	480
Boards Moderated	0
Alias Born	03/25/2014

Re: MT101 post# 1881

Thursday, 11/03/2022 3:01:16 PM

Thursday, November 03, 2022 3:01:16 PM

Apparently not

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SONN News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 12:45:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:41:20 PM
Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2024 12:35:00 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 09:28:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:05:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 12:36:15 PM
Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study • GlobeNewswire Inc. • 07/24/2024 12:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/16/2024 04:15:17 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/15/2024 09:05:56 PM
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:15:34 PM
Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain • GlobeNewswire Inc. • 06/13/2024 12:00:00 PM
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 11:35:12 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 01:25:20 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/16/2024 08:16:44 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/15/2024 08:06:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 09:25:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 09:07:54 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:26:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:30:24 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 12:35:22 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 12:30:31 PM

More SONN News

InvestorsHub NewsWire

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow